Nortech Systems (NSYS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
13 May, 2026Opening remarks and agenda
Meeting called to order by the CFO, with the President and CEO present, and key business partners from audit and legal firms acknowledged.
Board nominees and committee chairs introduced, including those for audit, nominating, science and technology, and compensation.
Record date for voting established as March 20, 2026, with quorum confirmed and Broadridge Financial Solutions appointed as inspector of elections.
Shareholder proposals
Proposals included election of six directors for a one-year term, advisory approval of executive compensation, approval of the 2026 Equity Incentive Plan, and ratification of the independent auditor for fiscal 2026.
Overview of voting outcomes
All six director nominees elected by required shareholder vote.
Advisory approval of executive compensation, the 2026 Equity Incentive Plan, and auditor ratification all received requisite approvals.
Ballots and proxies to be filed with company records, with a certificate of inspection attached to meeting minutes.
Latest events from Nortech Systems
- Net sales and backlog climbed on medical strength, with improved margins and new credit facility.NSYS
Q2 2026 - Net sales up 12.7%, gross margin at 15.5%, and backlog reached $90.8 million.NSYS
Q1 2026 - Annual meeting to vote on directors, pay, auditor, and new equity plan; board remains majority independent.NSYS
Proxy filing - Virtual annual meeting to vote on directors, compensation, auditor, and equity plan.NSYS
Proxy filing - Q4 sales and net income rose, backlog grew, and new debt financing supported momentum.NSYS
Q4 2025 - Annual meeting to vote on directors, executive pay, auditor, and say-on-pay frequency.NSYS
Proxy Filing - Q3 2024 sales and profit fell, but restructuring and investment target future growth.NSYS
Q3 2024 - Q2 net sales and income declined, but facility moves target $1.6M+ annual savings from 2025.NSYS
Q2 2024 - Q4 sales and margins fell sharply, but restructuring and R&D aim to restore growth.NSYS
Q4 2024